Alzheimer's drug lecanemab that slows decline given green light in UK - but won't be available on NHS - Sky News
- Alzheimer's drug lecanemab that slows decline given green light in UK - but won't be available on NHS Sky News
- UK health regulator rejects lecanemab as treatment for Alzheimer’s The Guardian
- Lecanemab licensed for adult patients in the early stages of Alzheimer’s disease GOV.UK
- Benefits of new Alzheimer’s treatment lecanemab are too small to justify the cost to the NHS NICE
- Live news: Breakthrough Alzheimer’s drug approved in UK but too costly for NHS Financial Times